VAT is active in releasing bio-active factors such as leptin, adiponectin, tumor necrosis factor-α, interleukin-6, interleukin-8, and MCP-1 that are involved in the pathogenesis of CVD, metabolic disorders, and T2DM (24, 25). This evidence concerns the gene CCL2 and type 2 diabetes mellitus.